Patent ID: 9603800
Date: 2017-03-28
CPC Classifications: A61K,A61P,B82Y,C07K

Claim:
1. A method of treating a subject with an inflammatory, allergic, or autoimmune disease or disorder comprising administering to the subject a composition comprising an effective amount of nanolipogels comprising a polymeric matrix formed of crosslinked polymer, amphiphilic polymer, block copolymer, or tri-block copolymer having dispersed therein or covalently bound thereto one or more host molecules which reversibly complex with or bind an agent, wherein the host molecules are selected from the group consisting of one or more polysaccharides, cryptands, cryptophanes, cavitands, crown ethers, dendrimers, catenanes, carcerands, spherands, carbon nanotubes and fullerenes, for controlled release of at least one therapeutic, diagnostic or prophylactic agent, and a lipid shell; wherein one or more active agents for reducing, decreasing, or alleviating one or more symptoms of the inflammatory, allergic, or autoimmune disease or disorder are reversibly complexed or bound to the host molecules, dispersed within the polymeric matrix, dispersed in or bound to the lipid shell, or combinations thereof.